Development of in vitro antimicrobial resistance in bacteria exposed to residue level exposures of antimicrobial drugs, pesticides and veterinary drugs

Chemotherapy

Volumn 53, Issue 2, 2007, Pages 132-136

  Kleiner, David K ^a   Katz, Stanley E ^a   Ward, Paula Marie L ^a  

^a The State University of New Jersey   (United States)

Author keywords

Agrochemical interactions; Antibiotic residues; Bacterial resistance; Drug combinations; Pesticides; Veterinary drugs

Indexed keywords

AGRICULTURAL CHEMICAL; AMPICILLIN; AMPROLIUM; ANTIBIOTIC AGENT; ANTIINFECTIVE AGENT; ARSANILIC ACID; CAPTAN; CARBARIL; ERYTHROMYCIN; FUNGICIDE; HERBICIDE; INSECTICIDE; IVERMECTIN; KANAMYCIN; LEVAMISOLE; MALATHION; METHOXYCHLOR; MONENSIN; NEOMYCIN; NORFLOXACIN; PESTICIDE; SULFATHIAZOLE; TETRACYCLINE; VETERINARY DRUG;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIUM; CONTROLLED STUDY; CROP PRODUCTION; ENVIRONMENTAL EXPOSURE; HUMAN; IN VITRO STUDY; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL; STAPHYLOCOCCUS AUREUS; VETERINARY MEDICINE;

ANTI-BACTERIAL AGENTS; DRUG INTERACTIONS; DRUG RESISTANCE, MULTIPLE, BACTERIAL; MICROBIAL SENSITIVITY TESTS; PESTICIDES; STAPHYLOCOCCUS AUREUS; VETERINARY DRUGS;

EID: 33847730231     PISSN: 00093157     EISSN: None     Source Type: Journal    
DOI: 10.1159/000100012     Document Type: Article

References (14)

1. Hignite C, Azarnoff DL: Drugs and drug metabolites as environmental contaminants: chlorophenoxyisobutyrate and salicylic acid in sewage water effluent. Life Sci 1977;20:337-341.
2. Richardson ML, Bowron JM: The fate of pharmaceutical chemicals in the aquatic environment. J Pharm Pharmacol 1985;37:1-12.
3. Herberer T, Stan HJ: Determination of clofibric acid and N-(phenylsulfonyl)-sarcosine in sewage, river and drinking water. Int J Environ Anal Chem 1997;67:113-124.
4. Hirsch R, Ternes T, Haberer T, Kratz KL: Occurrence of antibiotics in the aquatic environment. Sci Total Environ 1999;225:109-118.
5. Stumpf M, Ternes TA, Wilkens R-D, Rodriguez SV, Baumann W: Polar drug residues in sewage and natural waters in the state of Rio de Janeiro, Brazil. Sci Total Environ 1999;225:135-141.
6. Halling-Sorenson B, Nors-Nielson S, Lanzky PF, Ingerslev F, Holten-Lützhoff HC, Jorgensen SE: Occurrence, fate and effects of pharmaceutical substances in the environment - a review. Chemosphere 1998;36:357-393.
7. Kolpin DW, Furlong ET, Meyer MT, Thurman EM, Zaugg SD, Barber LB, Buxton HT: Pharmaceuticals, hormones and other waste water contaminants in U.S. streams, 1999-2000: a national reconnaissance. Environ Sci Technol 2002;36:1202-1211.
8. Barcia E, Negro S: Interactions of anti-infectives: a review. Chemotherapy 2005;51:197-199.
9. Goossens H: Europea status of resistance in nosocomial infections. Chemotherapy 2005;51:177-181
10. Jones RN, Barry AL, Gavin TL, Washington JA II: Susceptibility tests: microdilution and macrodilution broth procedures; in Lennette EH, Balows A, Hauser WJ Jr, Shodomy J (eds): Manual of Clinical Microbiology, ed 4. Washington, American Society for Microbiology, 1985, pp 972-977.
11. Bordas AA, Brady MS, Siewierski M, Katz SE: In vitro enhancement of antibiotic resistance development - interactions of residues of pesticides and antibiotics. J Food Prot 1997;60:532-536.
12. Daughton CG: PPCPs as environmental pollutants. Pharmaceutical and personal care products in the environment: overarching issues and overview. http://www.epa.gov/esd/chemistry/pharma/book-summary.htm.
13. Bard SM: Multixenobiotic resistance as a cellular defense mechanism in aquatic organisms. Aquatic Toxicol 2000;48:357-389.
14. Ward PL, Fasitsas S, Katz SE: Inhibition, resistance development and increased antibiotic and antimicrobial resistance caused by nutraceuticals. J Food Prot 2002;65:528-533.